Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opioids and the immune system.

Paola Sacerdote1

  • 1Department of Pharmacology, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy. paola.sacerdote@unimi.it

Palliative Medicine
|June 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychometric and Molecular Profiling to Predict Outcomes of Spinal Cord Stimulation for Chronic Pain: A Pilot Study.

Journal of pain research·2026
Same author

Reduced Neuroinflammation and Pain with a Functional Sourdough Bread Enriched with Legumes and Ancient Cereals in a Mouse Model of LPS-Induced Inflammation.

International journal of molecular sciences·2026
Same author

Insights into mesenchymal stem/stromal cell conditioned media as a long-lasting treatment for pain and psychiatric comorbidities in a murine model of osteoarthritis.

Brain, behavior, and immunity·2026
Same author

Cell-Free Therapies for Chronic Pain: The Rise of the Mesenchymal Stem Cell Secretome.

Brain sciences·2025
Same author

Protease-activated receptor 1-mediated matrix metalloprotease signaling in sensory neurons.

American journal of physiology. Cell physiology·2025
Same author

The prokineticin system and glia cells as pharmacological targets to control neuroinflammation and to relieve pain in a murine model of Fabry-Anderson disease.

Pain·2025
Same journal

Understanding workplace peer support among healthcare assistants providing palliative and end-of-life care at home: A realist review.

Palliative medicine·2026
Same journal

Exploring Pathways to Optimise Care in malignant bowel obstruction (EPOC): A realist review of shared decision-making with people with advanced cancer and severe symptoms.

Palliative medicine·2026
Same journal

Caregivers' perspectives on family meetings and preparedness for imminent death: A qualitative descriptive study in a palliative care setting.

Palliative medicine·2026
Same journal

Palliative care: The holy grail of healthcare interventions?

Palliative medicine·2026
Same journal

Social determinants of death anxiety in patients with advanced cancer receiving outpatient palliative care.

Palliative medicine·2026
Same journal

A Reflexivity Lab as a methodological tool in end-of-life research.

Palliative medicine·2026
See all related articles

Buprenorphine, unlike morphine and fentanyl, does not suppress the immune system. This study shows buprenorphine is a potent analgesic with a favorable safety profile for immune function.

Area of Science:

  • Immunology
  • Pharmacology
  • Pain Management

Background:

  • Opioids like morphine provide analgesia but can adversely affect immune responses.
  • Morphine's immunomodulatory effects include decreased cellular immunity, increasing infection and cancer risks in animal studies.
  • Individual opioid profiles vary, necessitating evaluation for appropriate analgesic selection.

Purpose of the Study:

  • To compare the immunomodulatory effects of buprenorphine, morphine, and fentanyl.
  • To assess the impact of these opioids on natural killer (NK)-lymphocyte activity following surgical stress.
  • To determine if buprenorphine possesses a more favorable immune profile compared to other potent analgesics.

Main Methods:

  • Animal studies (rats and mice) were used to investigate opioid effects on immune parameters.

Related Experiment Videos

  • Compared acute and chronic administration of buprenorphine, morphine, and fentanyl.
  • Examined NK-lymphocyte activity in rats after experimental surgery and opioid treatment.

    • Main Results:

    • Buprenorphine did not affect cellular immune responses in rats, unlike morphine.
    • Chronic buprenorphine administration in mice did not alter key immune markers for antimicrobial and anti-tumor surveillance.
    • Morphine and fentanyl showed immunosuppressive effects, with buprenorphine demonstrating the most favorable immune profile, restoring NK-lymphocyte activity post-surgery.

    Conclusions:

    • Buprenorphine is a potent analgesic with minimal to no intrinsic immunosuppressive activity.
    • Opioid-induced immunomodulation varies significantly between different compounds.
    • Buprenorphine represents a safer analgesic option regarding immune system function compared to morphine and fentanyl.